Maxion Therapeutics
2 employees
Biotech
Series A · $88.0M
Open positions (1)
Company details
Team Size2
IndustryBiotech
Funding
Total raised
$88.0M
Last stage
Series A
Investors
British Patient Capital
Total raised
$88.0M
Last stage
Series A
Investors
Dr. John McCafferty
Co-founded Maxion Therapeutics in 2020. Previously co-founded Cambridge Antibody Technology (acquired by AstraZeneca) and IONTAS (acquired by FairJourney Biologics). Co-invented antibody phage display, the subject of the 2018 Nobel Prize in Chemistry.
LinkedIn
Dr. Aneesh Karatt-Vellatt
Co-invented the KnotBody® technology. Previously co-founder of IONTAS Ltd. Holds a PhD in Biochemistry from the University of Cambridge. Over 10 years of experience in antibody and protein drug discovery at AstraZeneca, University of Cambridge, and IONTAS.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.